Centers for Disease Control and Prevention. National Diabetes Statistics Report 2022. [Available from: https://www.cdc.gov/diabetes/data/statistics-report/index.html.

Yuan Z, Tang Z, He C, Tang W. Diabetic cystopathy: a review. J Diabetes. 2015;7(4):442–7. https://doi.org/10.1111/1753-0407.12272.

Article  PubMed  Google Scholar 

Blair Y, Wessells H, Pop-Busui R, Ang L, Sarma AV. Urologic complications in diabetes. J Diabetes Complications. 2022;36(10):108288. https://doi.org/10.1016/j.jdiacomp.2022.108288.

Article  PubMed  PubMed Central  Google Scholar 

Brown JS, Wessells H, Chancellor MB, Howards SS, Stamm WE, Stapleton AE, Steers WD, Van Den Eeden SK, McVary KT. Urologic complications of diabetes. Diabetes Care. 2005;28(1):177–85. https://doi.org/10.2337/diacare.28.1.177.

Article  PubMed  Google Scholar 

Kaplan SA, Te AE, Blaivas JG. Urodynamic findings in patients with diabetic cystopathy. J Urol. 1995;153(2):342–4.

Article  CAS  PubMed  Google Scholar 

Daneshgari F, Liu G, Birder L, Hanna-Mitchell AT, Chacko S. Diabetic bladder dysfunction: current translational knowledge. J Urol. 2009;182(6 Suppl):S18-26. https://doi.org/10.1016/j.juro.2009.08.070.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qasrawi H, Tabouni M, Almansour SW, Ghannam M, Abdalhaq A, Abushamma F, Koni AA, Zyoud SH. An evaluation of lower urinary tract symptoms in diabetic patients: a cross-sectional study. BMC Urol. 2022;22(1):178. https://doi.org/10.1186/s12894-022-01133-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wessells H, Braffett BH, Holt SK, Jacobson AM, Kusek JW, Cowie C, Dunn RL, Sarma AV. Burden of urological complications in men and women with long-standing type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort. Diabetes Care. 2018;41(10):2170–7. https://doi.org/10.2337/dc18-0255.

Article  PubMed  PubMed Central  Google Scholar 

Erdogan BR, Liu G, Arioglu-Inan E, Michel MC. Established and emerging treatments for diabetes-associated lower urinary tract dysfunction. Naunyn Schmiedebergs Arch Pharmacol. 2022;395(8):887–906. https://doi.org/10.1007/s00210-022-02249-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Daniels DH, Powell CR, Braasch MR, Kreder KJ. Sacral neuromodulation in diabetic patients: success and complications in the treatment of voiding dysfunction. Neurourol Urodyn. 2010;29(4):578–81. https://doi.org/10.1002/nau.20791.

Article  PubMed  Google Scholar 

Daneshgari F, Liu G, Imrey PB. Time dependent changes in diabetic cystopathy in rats include compensated and decompensated bladder function. J Urol. 2006;176(1):380–6. https://doi.org/10.1016/S0022-5347(06)00582-9.

Article  PubMed  Google Scholar 

Wittig L, Carlson KV, Andrews JM, Crump RT, Baverstock RJ. Diabetic bladder dysfunction: a review. Urology. 2019;123:1–6. https://doi.org/10.1016/j.urology.2018.10.010.

Article  PubMed  Google Scholar 

Inouye BM, Hughes FM Jr, Jin H, Lütolf R, Potnis KC, Routh JC, Rouse DC, Foo WC, Purves JT. Diabetic bladder dysfunction is associated with bladder inflammation triggered through hyperglycemia, not polyuria. Res Rep Urol. 2018;10:219–25. https://doi.org/10.2147/rru.S177633.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hughes FM Jr, Vivar NP, Kennis JG, Pratt-Thomas JD, Lowe DW, Shaner BE, Nietert PJ, Spruill LS, Purves JT. Inflammasomes are important mediators of cyclophosphamide-induced bladder inflammation. Am J Physiol Renal Physiol. 2014;306(3):F299-308. https://doi.org/10.1152/ajprenal.00297.2013.

Article  CAS  PubMed  Google Scholar 

Hughes FM Jr, Turner DP, Purves JT. The potential repertoire of the innate immune system in the bladder: expression of pattern recognition receptors in the rat bladder and a rat urothelial cell line (MYP3 cells). Int Urol Nephrol. 2015;47(12):1953–64. https://doi.org/10.1007/s11255-015-1126-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hughes FM Jr, Hill HM, Wood CM, Edmondson AT, Dumas A, Foo WC, Oelsen JM, Rac G, Purves JT. The NLRP3 inflammasome mediates inflammation produced by bladder outlet obstruction. J Urol. 2016;195:1598–605. https://doi.org/10.1016/j.juro.2015.12.068.

Article  CAS  PubMed  Google Scholar 

Odom MR, Hughes FM Jr, Jin H, Purves JT. Diabetes causes NLRP3-dependent barrier dysfunction in mice with detrusor overactivity but not underactivity. Am J Physiol Renal Physiol. 2022;323(6):F616–32. https://doi.org/10.1152/ajprenal.00047.2022.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Serhan CN, Hamberg M, Samuelsson B. Trihydroxytetraenes: a novel series of compounds formed from arachidonic acid in human leukocytes. Biochem Biophys Res Commun. 1984;118(3):943–9. https://doi.org/10.1016/0006-291x(84)91486-4.

Article  CAS  PubMed  Google Scholar 

Serhan CN, Hamberg M, Samuelsson B. Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc Natl Acad Sci U S A. 1984;81(17):5335–9. https://doi.org/10.1073/pnas.81.17.5335.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Serhan CN, Chiang N. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br J Pharmacol. 2008;153(Suppl 1):S200–15. https://doi.org/10.1038/sj.bjp.0707489.

Article  CAS  PubMed  Google Scholar 

Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510(7503):92–101. https://doi.org/10.1038/nature13479.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Serhan CN. Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology. Mol Aspects Med. 2017;58:1–11. https://doi.org/10.1016/j.mam.2017.03.001.

Article  PubMed  PubMed Central  Google Scholar 

Serhan CN, Chiang N, Dalli J, Levy BD. Lipid mediators in the resolution of inflammation. Cold Spring Harb Perspect Biol. 2014;7(2):a016311. https://doi.org/10.1101/cshperspect.a016311.

Article  PubMed  Google Scholar 

Perucci LO, Sugimoto MA, Gomes KB, Dusse LM, Teixeira MM, Sousa LP. Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases. Expert Opin Ther Targets. 2017;21(9):879–96. https://doi.org/10.1080/14728222.2017.1364363.

Article  CAS  PubMed  Google Scholar 

Ge YJ, Liao QW, Xu YC, Zhao Q, Wu BL, Ye RD. Anti-inflammatory signaling through G protein-coupled receptors. Acta Pharmacol Sin. 2020;41(12):1531–8. https://doi.org/10.1038/s41401-020-00523-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mastromarino M, Lacivita E, Colabufo NA, Leopoldo M. G-protein coupled receptors involved in the resolution of inflammation: ligands and therapeutic perspectives. Mini Rev Med Chem. 2020;20(20):2090–103. https://doi.org/10.2174/1389557520666200719014433.

Article  CAS  PubMed  Google Scholar 

Basil MC, Levy BD. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol. 2016;16(1):51–67. https://doi.org/10.1038/nri.2015.4.

Article  CAS  PubMed  Google Scholar 

Hasturk H, Schulte F, Martins M, Sherzai H, Floros C, Cugini M, Chiu CJ, Hardt M, Van Dyke T. Safety and preliminary efficacy of a novel host-modulatory therapy for reducing gingival inflammation. Front Immunol. 2021;12:704163.